SLeX decorated integrin α3 on sEVs promotes metastasis of bladder cancer via enhancing vascular permeability
Cited by 0
Related Papers
Safety, efficacy and tumor mutational burden as a biomarker of overall survival benefit in chemo-refractory gastric cancer treated with toripalimab, a PD-1 antibody in phase Ib/II clinical trial NCT02915432
|Annals of Oncology|2019|475
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
|Journal of Clinical Oncology|2021|350
Toripalimab plus chemotherapy as second-line treatment in previously EGFR-TKI treated patients with EGFR-mutant-advanced NSCLC: a multicenter phase-II trial
|Signal Transduction and Targeted Therapy|2021|94
Zebrafish B Cell Development without a Pre–B Cell Stage, Revealed by CD79 Fluorescence Reporter Transgenes
|The Journal of Immunology|2017|54
Astragaloside IV ameliorates diabetic nephropathy in <i>db/db</i> mice by inhibiting NLRP3 inflammasome‑mediated inflammation
|International Journal of Molecular Medicine|2021|51